Avita Medical (RCEL) Competitors $5.35 -0.53 (-9.01%) Closing price 07/15/2025 04:00 PM EasternExtended Trading$5.47 +0.12 (+2.17%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RCEL vs. SMLR, EMBC, CBLL, BVS, BBNX, AVNS, AXGN, KIDS, BFLY, and DCTHShould you be buying Avita Medical stock or one of its competitors? The main competitors of Avita Medical include Semler Scientific (SMLR), Embecta (EMBC), CeriBell (CBLL), Bioventus (BVS), Beta Bionics (BBNX), Avanos Medical (AVNS), AxoGen (AXGN), OrthoPediatrics (KIDS), Butterfly Network (BFLY), and Delcath Systems (DCTH). These companies are all part of the "medical equipment" industry. Avita Medical vs. Its Competitors Semler Scientific Embecta CeriBell Bioventus Beta Bionics Avanos Medical AxoGen OrthoPediatrics Butterfly Network Delcath Systems Semler Scientific (NASDAQ:SMLR) and Avita Medical (NASDAQ:RCEL) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, profitability, risk, analyst recommendations, dividends and institutional ownership. Do insiders & institutionals believe in SMLR or RCEL? 49.4% of Semler Scientific shares are held by institutional investors. Comparatively, 27.7% of Avita Medical shares are held by institutional investors. 30.2% of Semler Scientific shares are held by company insiders. Comparatively, 2.8% of Avita Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has better valuation and earnings, SMLR or RCEL? Semler Scientific has higher earnings, but lower revenue than Avita Medical. Semler Scientific is trading at a lower price-to-earnings ratio than Avita Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSemler Scientific$56.29M10.26$40.90M-$2.61-16.16Avita Medical$64.25M2.20-$61.85M-$2.19-2.44 Is SMLR or RCEL more profitable? Semler Scientific has a net margin of -60.69% compared to Avita Medical's net margin of -79.61%. Semler Scientific's return on equity of 19.75% beat Avita Medical's return on equity.Company Net Margins Return on Equity Return on Assets Semler Scientific-60.69% 19.75% 15.47% Avita Medical -79.61%-632.62%-71.72% Do analysts prefer SMLR or RCEL? Semler Scientific currently has a consensus price target of $89.00, indicating a potential upside of 111.00%. Avita Medical has a consensus price target of $16.50, indicating a potential upside of 208.41%. Given Avita Medical's higher probable upside, analysts clearly believe Avita Medical is more favorable than Semler Scientific.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Semler Scientific 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33Avita Medical 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 Which has more risk & volatility, SMLR or RCEL? Semler Scientific has a beta of 1.39, indicating that its share price is 39% more volatile than the S&P 500. Comparatively, Avita Medical has a beta of 1.52, indicating that its share price is 52% more volatile than the S&P 500. Does the media refer more to SMLR or RCEL? In the previous week, Semler Scientific had 11 more articles in the media than Avita Medical. MarketBeat recorded 12 mentions for Semler Scientific and 1 mentions for Avita Medical. Avita Medical's average media sentiment score of 1.87 beat Semler Scientific's score of 0.51 indicating that Avita Medical is being referred to more favorably in the news media. Company Overall Sentiment Semler Scientific Positive Avita Medical Very Positive SummarySemler Scientific beats Avita Medical on 10 of the 17 factors compared between the two stocks. Get Avita Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for RCEL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RCEL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RCEL vs. The Competition Export to ExcelMetricAvita MedicalMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$155.44M$2.44B$5.61B$9.29BDividend YieldN/A1.79%4.23%4.03%P/E Ratio-2.449.1428.5419.58Price / Sales2.20679.15429.2495.01Price / CashN/A164.3436.0257.93Price / Book31.474.608.145.54Net Income-$61.85M$30.99M$3.24B$257.73M7 Day Performance-4.97%-1.81%0.18%-0.08%1 Month Performance-2.19%5.73%5.96%8.09%1 Year Performance-48.56%-7.03%26.24%13.02% Avita Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RCELAvita Medical1.3532 of 5 stars$5.35-9.0%$16.50+208.4%-45.7%$155.44M$64.25M-2.44130Positive NewsSMLRSemler Scientific2.5946 of 5 stars$45.23-0.7%$89.00+96.8%+21.4%$619.20M$56.29M-17.33120EMBCEmbecta4.7532 of 5 stars$10.37-1.0%$19.33+86.4%-25.4%$606.05M$1.08B11.522,100News CoveragePositive NewsCBLLCeriBell2.6078 of 5 stars$16.38+1.5%$32.14+96.2%N/A$591.97M$65.44M0.00N/ABVSBioventus2.7105 of 5 stars$6.81-2.3%$13.75+101.9%-4.3%$559.40M$567.70M-11.161,200BBNXBeta BionicsN/A$12.83+1.3%$23.44+82.7%N/A$556.31M$65.12M0.00294AVNSAvanos Medical2.8803 of 5 stars$11.85-0.6%N/A-44.8%$548.13M$687.80M-1.422,227News CoverageAXGNAxoGen2.3019 of 5 stars$12.02+1.1%$24.50+103.8%+34.8%$547.39M$187.34M-80.13450KIDSOrthoPediatrics4.2538 of 5 stars$22.14+1.1%$35.83+61.8%-33.1%$537.78M$204.73M-12.65200Analyst ForecastBFLYButterfly Network2.3862 of 5 stars$1.83+0.8%$3.50+91.8%+47.5%$451.30M$82.06M-6.29460DCTHDelcath Systems2.891 of 5 stars$11.87+4.7%$24.00+102.2%+38.4%$413.43M$37.21M-23.7460High Trading Volume Related Companies and Tools Related Companies Semler Scientific Alternatives Embecta Alternatives CeriBell Alternatives Bioventus Alternatives Beta Bionics Alternatives Avanos Medical Alternatives AxoGen Alternatives OrthoPediatrics Alternatives Butterfly Network Alternatives Delcath Systems Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RCEL) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avita Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Avita Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RCEL Stock Alerts